Summary
MetLife Inc.'s (MET) Form 10-Q/A filed on November 21, 2010, provides an amended look at its financial performance for the period ending March 30, 2010. While the filing itself is an amendment, indicating a need for corrections or additions to the original report, it's crucial for investors to note the period covered. The detailed financial discussion is found in Item 2, covering the Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations, which would contain the core operational and financial insights. Investors should scrutinize the MD&A for details on revenue streams, profitability drivers, and any significant changes in the company's financial position during that quarter.
Financial Highlights
33 data pointsBeta
Financial Statements
Beta
| Revenue | $13.10B |
| Operating Expenses | $2.93B |
| Operating Income | $800.00M |
| Interest Expense | $370.00M |
| Net Income | $835.00M |
| EPS (Basic) | $0.98 |
| EPS (Diluted) | $0.97 |
| Shares Outstanding (Basic) | 822.65M |
| Shares Outstanding (Diluted) | 828.62M |
Key Highlights
- 1The filing is an amendment (10-Q/A) to a prior quarterly report for the period ending March 30, 2010.
- 2Item 2 contains the Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations, the primary section for understanding performance.
- 3Investors should review the MD&A for details on revenue generation, expense management, and investment performance.
- 4The report covers financial data from the first quarter of 2010.
- 5Item 6 lists the exhibits filed with the report, which may contain supporting documentation.